Dr. Ankit Patel, M.D

NPI: 1083979322
Total Payments
$21,121
2024 Payments
$2,953
Companies
81
Transactions
1,298
Medicare Patients
2,227
Medicare Billing
$269,801

Payment Breakdown by Category

Food & Beverage$20,558 (97.3%)
Education$328.30 (1.6%)
Other$234.21 (1.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $20,558 1,273 97.3%
Education $328.30 10 1.6%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $234.21 15 1.1%

Top Paying Companies

Company Total Records Latest Year
Teva Pharmaceuticals USA, Inc. $3,351 214 $0 (2024)
UCB, Inc. $1,068 49 $0 (2024)
Novartis Pharmaceuticals Corporation $1,015 80 $0 (2024)
ABBVIE INC. $995.18 57 $0 (2024)
Genentech USA, Inc. $981.33 63 $0 (2024)
EMD Serono, Inc. $963.79 98 $0 (2024)
GENZYME CORPORATION $871.76 48 $0 (2022)
SK Life Science, Inc. $858.14 57 $0 (2024)
ACADIA Pharmaceuticals Inc $744.75 49 $0 (2024)
Biogen, Inc. $641.63 50 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,953 155 UCB, Inc. ($445.46)
2023 $3,239 172 UCB, Inc. ($366.09)
2022 $3,368 189 Abbott Laboratories ($269.53)
2021 $2,927 186 Teva Pharmaceuticals USA, Inc. ($577.30)
2020 $1,997 124 Teva Pharmaceuticals USA, Inc. ($308.93)
2019 $2,142 142 Teva Pharmaceuticals USA, Inc. ($616.57)
2018 $2,705 196 Teva Pharmaceuticals USA, Inc. ($1,043)
2017 $1,790 134 Teva Pharmaceuticals USA, Inc. ($292.68)

All Payment Transactions

1,298 individual payment records from CMS Open Payments — Page 1 of 52

Date Company Product Nature Form Amount Type
12/31/2024 Abbott Laboratories INFINITY (Device) Food and Beverage In-kind items and services $19.17 General
Category: Neuromodulation
12/23/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $31.17 General
Category: Neurology
12/19/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $14.08 General
Category: PAIN
12/18/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $14.13 General
Category: PARKINSONS DISEASE PSYCHOSIS
12/17/2024 UCB, Inc. Fintepla (Drug) Food and Beverage In-kind items and services $20.12 General
Category: Neurology
12/17/2024 Lilly USA, LLC EMGALITY (Drug) Food and Beverage In-kind items and services $17.32 General
Category: Neuroscience
12/11/2024 Azurity Pharmaceuticals, Inc. HORIZANT (Drug) Food and Beverage In-kind items and services $16.96 General
Category: CEREBROVASCULARCNS
12/09/2024 UCB, Inc. Rystiggo (Drug) Food and Beverage In-kind items and services $28.04 General
Category: Neurology
12/05/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $14.25 General
Category: Neuroscience
12/04/2024 Genentech USA, Inc. Ocrevus (Biological), Ocrevus Zunovo Food and Beverage In-kind items and services $18.72 General
Category: Immunology
12/04/2024 UCB, Inc. Rystiggo (Drug) Food and Beverage In-kind items and services $12.00 General
Category: Neurology
12/03/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $18.39 General
Category: PAIN
12/02/2024 SK Life Science, Inc. Food and Beverage In-kind items and services $15.45 General
11/26/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $11.19 General
Category: PAIN
11/25/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $20.86 General
Category: Neurology
11/21/2024 Lilly USA, LLC EMGALITY (Drug) Food and Beverage In-kind items and services $16.08 General
Category: Neuroscience
11/20/2024 Takeda Pharmaceuticals U.S.A., Inc. HYQVIA (Biological) Food and Beverage In-kind items and services $17.10 General
Category: IMMUNOLOGY
11/19/2024 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $32.66 General
Category: Neurology
11/14/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $19.80 General
Category: PAIN
11/13/2024 UCB, Inc. Rystiggo (Drug) Food and Beverage In-kind items and services $25.57 General
Category: Neurology
11/13/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $23.89 General
Category: Rare Disease
11/11/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $14.93 General
Category: PSYCHIATRY
11/07/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $21.79 General
Category: NEUROSCIENCE
11/06/2024 Abbott Laboratories INFINITY (Device) Food and Beverage In-kind items and services $26.44 General
Category: Neuromodulation
11/05/2024 Genentech USA, Inc. Ocrevus Zunovo (Biological) Food and Beverage In-kind items and services $21.81 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 616 805 $214,384 $76,846
2022 12 517 669 $165,464 $61,992
2021 13 593 776 $198,208 $80,639
2020 9 501 628 $136,803 $50,324
Total Patients
2,227
Total Services
2,878
Medicare Billing
$269,801
Procedure Codes
49

All Medicare Procedures & Services

49 procedure records from CMS Medicare Utilization — Page 2 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 202 317 $71,642 $29,776 41.6%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 56 69 $20,838 $9,854 47.3%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 44 44 $18,480 $7,324 39.6%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 52 52 $17,680 $6,082 34.4%
95886 Needle measurement and recording of electrical activity of muscles of arm or leg complete study Office 2021 30 60 $12,120 $5,220 43.1%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 30 30 $12,900 $5,117 39.7%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 52 59 $9,204 $3,586 39.0%
95910 Nerve transmission studies, 7-8 studies Office 2021 18 18 $7,200 $2,885 40.1%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 27 39 $5,850 $2,330 39.8%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 17 22 $4,752 $1,889 39.8%
99205 New patient outpatient visit, total time 60-74 minutes Facility 2021 12 12 $5,160 $1,860 36.0%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 14 14 $4,004 $1,582 39.5%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 11 11 $3,740 $1,255 33.6%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 11 11 $2,442 $1,006 41.2%
95819 Measurement and recording of brain wave (eeg) activity, awake and asleep Facility 2021 17 18 $2,196 $873.72 39.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 174 252 $55,567 $18,567 33.4%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 82 82 $27,487 $10,114 36.8%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 49 50 $20,611 $8,271 40.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 81 90 $13,580 $4,441 32.7%
95886 Needle measurement and recording of electrical activity of muscles of arm or leg complete study Office 2020 20 40 $7,503 $3,280 43.7%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 29 42 $6,170 $2,503 40.6%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2020 34 38 $3,016 $1,865 61.8%
95819 Measurement and recording of brain wave (eeg) activity, awake and asleep Facility 2020 18 20 $2,366 $983.06 41.5%
99441 Physician telephone patient service, 5-10 minutes of medical discussion Office 2020 14 14 $504.31 $299.60 59.4%

About Dr. Ankit Patel, M.D

Dr. Ankit Patel, M.D is a Neurology healthcare provider based in Katy, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2012. The National Provider Identifier (NPI) number assigned to this provider is 1083979322.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ankit Patel, M.D has received a total of $21,121 in payments from pharmaceutical and medical device companies, with $2,953 received in 2024. These payments were reported across 1,298 transactions from 81 companies. The most common payment nature is "Food and Beverage" ($20,558).

As a Medicare-enrolled provider, Patel has provided services to 2,227 Medicare beneficiaries, totaling 2,878 services with total Medicare billing of $269,801. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Other Specialties Student in an Organized Health Care Education/Training Program
  • Location Katy, TX
  • Active Since 07/12/2012
  • Last Updated 09/19/2024
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1083979322

Products in Payments

  • AJOVY (Drug) $1,061
  • AJOVY (Biological) $983.08
  • NUPLAZID (Drug) $744.75
  • COPAXONE (Drug) $729.13
  • KESIMPTA (Drug) $727.97
  • OCREVUS (Biological) $727.01
  • AUBAGIO (Drug) $702.78
  • INFINITY (Device) $579.32
  • APTIOM (Drug) $554.12
  • NURTEC ODT (Drug) $490.91
  • UBRELVY (Drug) $430.67
  • ACTHAR (Biological) $364.46
  • Gamunex-C (Biological) $360.66
  • QULIPTA (Drug) $352.11
  • Rebif (Biological) $347.68
  • TECFIDERA (Drug) $346.65
  • VALTOCO (Drug) $323.63
  • GAMMAGARD (Biological) $314.86
  • EMGALITY (Drug) $307.91
  • ULTOMIRIS (Biological) $302.32

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Katy